Jinling Pharmaceutical Company Limited (SHE:000919)
China · Delayed Price · Currency is CNY 8.58
-0.33 (-3.70%)
Apr 9, 2026, 3:04 PM CST
SHE:000919 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 51.29 | 40.41 | 106.19 | 105.28 | 120.63 |
Depreciation & Amortization | 161.22 | 150.16 | 151.2 | 124.34 | 122.95 |
Other Amortization | 12.55 | 18.96 | 7.06 | 6.04 | 5.31 |
Loss (Gain) From Sale of Assets | 0.39 | -21.34 | 0.56 | -62.58 | -51.98 |
Asset Writedown & Restructuring Costs | 20.09 | 96.32 | 0.15 | 0.84 | 47.53 |
Loss (Gain) From Sale of Investments | -30.2 | -54 | -32.11 | 12.26 | 2.86 |
Provision & Write-off of Bad Debts | - | 1.76 | 3.2 | 1.66 | -1.67 |
Other Operating Activities | -14.38 | -19.92 | 24.05 | 9.15 | 35.27 |
Change in Accounts Receivable | 5.12 | -90.63 | 88.99 | -56.17 | -107.93 |
Change in Inventory | 37.46 | 18.79 | -27.94 | 7.99 | -30.04 |
Change in Accounts Payable | -63.49 | 11.01 | -100.18 | 129.54 | 148.97 |
Change in Other Net Operating Assets | -3.46 | - | - | - | - |
Operating Cash Flow | 174.21 | 154.19 | 212.02 | 260.59 | 292.03 |
Operating Cash Flow Growth | 12.98% | -27.28% | -18.64% | -10.76% | -6.24% |
Capital Expenditures | -157.87 | -201.63 | -237.88 | -309.64 | -162.76 |
Sale of Property, Plant & Equipment | 0.12 | 22.1 | 23.67 | 80.06 | 64.93 |
Cash Acquisitions | - | -261.2 | - | -21.77 | - |
Divestitures | - | - | - | - | -1.25 |
Investment in Securities | -188.79 | -313.9 | -276.43 | 4.89 | 0.56 |
Other Investing Activities | 37.13 | 36.92 | 40.74 | 25.35 | 29.4 |
Investing Cash Flow | -309.41 | -717.7 | -449.89 | -221.11 | -69.12 |
Short-Term Debt Issued | - | - | - | 1.96 | 15 |
Long-Term Debt Issued | - | 150 | 0.31 | - | - |
Total Debt Issued | - | 150 | 0.31 | 1.96 | 15 |
Long-Term Debt Repaid | - | -3.96 | -5.01 | -22.83 | -1.37 |
Net Debt Issued (Repaid) | - | 146.04 | -4.7 | -20.86 | 13.63 |
Issuance of Common Stock | - | 744 | 3.38 | 23.62 | - |
Repurchase of Common Stock | - | -18.76 | - | - | - |
Common Dividends Paid | -67.51 | -63.24 | -51.16 | -51.16 | -50.66 |
Other Financing Activities | -17.56 | -1.62 | 8.93 | 2.15 | -2.61 |
Financing Cash Flow | -85.08 | 806.42 | -43.55 | -46.26 | -39.65 |
Foreign Exchange Rate Adjustments | 0.01 | 0.04 | 0.02 | 0.08 | -0 |
Net Cash Flow | -220.26 | 242.94 | -281.4 | -6.71 | 183.26 |
Free Cash Flow | 16.34 | -47.44 | -25.85 | -49.05 | 129.26 |
Free Cash Flow Growth | - | - | - | - | 544.48% |
Free Cash Flow Margin | 0.51% | -1.45% | -0.81% | -1.84% | 4.60% |
Free Cash Flow Per Share | 0.03 | -0.08 | -0.05 | -0.10 | 0.26 |
Cash Income Tax Paid | 102.31 | 92.04 | 128.02 | 97.66 | 104.08 |
Levered Free Cash Flow | -382.59 | -80.2 | 12.52 | -134.95 | 55.68 |
Unlevered Free Cash Flow | -382.59 | -78.83 | 13.33 | -134.79 | 55.86 |
Change in Working Capital | -26.74 | -58.16 | -48.27 | 63.6 | 11.12 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.